Department of Anesthesiology, Intensive Care and Pain Medicine, University Hospital of Muenster, Muenster, Germany.
Curr Opin Anaesthesiol. 2012 Oct;25(5):563-5. doi: 10.1097/ACO.0b013e3283572274.
In patients with traumatic brain injury (TBI), dysfunction of the neurovascular unit ('blood-brain barrier') is a common finding, resulting in maldistribution of water and osmoles within the brain. The purpose of the present article is to review the underlying physiology of osmolality and fluid therapy in TBI.
The findings of the 'Saline versus Albumin Fluid Evaluation' study suggest that infusion of colloidal solutions is associated with adverse outcomes as compared with sole crystalloid infusion in patients suffering from TBI. Comparison of calculated osmolarity and measured in-vitro osmolality suggests that human albumin solutions, Hartmann's solution, and, to a lesser extent, gelatine preparations are hypo-osmolar, and may, therefore, increase brain volume and intracranial pressure.
In the context of the published literature on this topic, it appears that the osmolality of an infusion solution rather than the colloid osmotic pressure per se represents the key determinant in the pathogenesis of cerebral edema formation.
颅脑损伤(TBI)患者常见神经血管单元(“血脑屏障”)功能障碍,导致脑内水和渗透物分布异常。本文旨在综述 TBI 中渗透压和液体治疗的基础生理学。
“盐水与白蛋白液的评估”研究结果表明,与单纯晶体液输注相比,胶体溶液输注与颅脑损伤患者的不良结局相关。计算渗透压与体外测量渗透压的比较表明,人血白蛋白溶液、哈特曼溶液和在较小程度上的明胶制剂呈低渗状态,因此可能会增加脑体积和颅内压。
根据该主题的已发表文献,似乎是输注溶液的渗透压,而不是胶体渗透压本身,代表脑水肿形成发病机制中的关键决定因素。